Abstract
Background
Primary fallopian tube carcinoma (PFTC) represents less than 1% of all gynecological malignancies and its association with diabetes mellitus is seldom reported.
Cases
We report three cases of PFTC presented primarily as advanced ovarian cancer while the primary site totally silent. Two of them were diabetics and showed expression of insulin-like growth factor receptors, Wilm’s tumor protein-1, c-kit and P16. In all these cases there was neither clinical nor perioperative suspicion of PFTC and the first clinical diagnosis was ovarian carcinoma which was supported by positive cytology for ascitic fluid and raised serum level of CA125. The diagnosis was only established after histopathologic examination of serial sections of the whole fallopian tube since we were able to demonstrate the continuity between the invasive and the in situ components of PFTC in the lining epithelial layer of the fallopian tube.
Conclusion
The presence of malignant cells in the female pelvic organs without a mass should raise the possibility of primary fallopian tube carcinoma. Pre-operative diagnosis of PFTC is seldom made and most of the time the diagnosis is made after histopathological examination as in our cases. Diabetes mellitus can be a risk factor in the development of PFTC.
Similar content being viewed by others
References
SPectasides D, Pectasides E, Economopoulos T (2006) Fallopian tube carcinoma: a review. Oncologist 11:902–912
Liapis A, Michailidis E, Deligeoroglou E, Kondi-Pafiti A, Konidaris S, Creatsas G (2004) Primary fallopian tube cancer–a ten year review. Clinicopathological study of 12 cases. Eur J Gynaecol Oncol 25:522–524
Klein M, Rosen A, Graf A, Lahousen M, Kucera H, Pakisch B, Vavra N, Beck A (1994) Primary fallopian tube carcinoma–a retrospective survey of 51 cases. Austrian cooperative study group for fallopian tube carcinoma. Arch Gynecol Obstet 255:141–146
Wolfson AH, Tralins KS, Greven KM, Kim RY, Corn BW, Kuettel MR, Philippart C, Raub WA, Randall ME (1998) Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients. Int J Radiat Oncol Biol Phys 40:71–76
Alvarado-Cabrero I, Young RH, Vamvakas EC, Scully RE (1999) Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 72:367–379
Butler DF, Bolton ME, Spanos WJ, Day TG, Paris KJ, Jose BO, Ackerman DM, Cornett MS, Lindberg RD (1999) Retrospective analysis of patients with primary fallopian tube carcinoma treated at the University of Louisville. J Ky Med Assoc 97:154–164
Singer CF, Hudelist G, Lamm W, Mueller R, Czerwenka K, Kubista E (2004) Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors. Endocr Relat Cancer 11:861–869
Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher III FJ (1991) Characterization of the zinc finger protein encoded by the WT1 Wilms’tumor locus. Oncogene 6:2339–2348
Lee SB, Huang K, Palmer R, Truong VB, Herzlinger D, Kolquist KA, Wong J, Paulding C, Yoon SK, Gerald W, Oliner JD, Haber DA (1999) The Wilms’ tumor suppressor WT1 encodes a transcriptional activator of amphiregulin. Cell 98:663–673
Erdogan G, Bassorgun CI, Pestereli HE, Simsek T, Karaveli (2007) C-kit protein expression in uterine and ovarian mesenchymal tumours. APMIS 115:204–209
Shapiro GI, Edwards CD, Ewen ME, Rollins BJ (1998) p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 18:378–387
Tulunay G, Arvas M, Demir B, Demirkiran F, Boran N, Bese T, Ozgul N, Kose MF, Kosebay D (2004) Primary fallopian tube carcinoma: a retrospective multicenter study. Eur J Gynaecol Oncol 25:611–614
Varras M, Akrivis Ch, Bellou A, Malamou-Mitsi VD, Antoniou N, Tolis C, Salamalekis E (2004) Primary fallopian tube adenocarcinoma: preoperative diagnosis, treatment and follow-up. Eur J Gynaecol Oncol 25:640–646
Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353
Wolf G, Wenzel U, Ziyadeh FN, Stahl RA (1999) Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats. Diabetologia 42:1425–1432
Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H, et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316(5829):1336–1341
Kelly DJ, Zhang Y, Gow RM, Itescu S, Gilbert RE (2005) Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes. Diab Vasc Dis Res 2:76–80
Pickel H, Reich O, Tamussino K (1998) Bilateral atypical hyperplasia of the fallopian tube associated with Tamoxifen: a report of two cases. Int J Gynecol Pathol 17:284–285
Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J (2003) Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol 21:4222–4227
Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P, Verheijen RH (2001) Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 195:451–456
Deffieux X, Morice P, Thoury A, Camatte S, Duvillard P, Castaigne D (2005) Anatomy of pelvic and para-aortic nodal spread in patients with primary fallopian tube carcinoma. J Am Coll Surg 200:45–48
Kosary C, Trimble EL (2002) Treatment and survival for women with fallopian tube carcinoma: a population-based study. Gynecol Oncol 86:190–191
Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G (2001) Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol 81:150–159
Acknowledgments
The authors would like to acknowledge Prof. Ernest Adeghate in the Anatomy department, in the Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE, for his support during this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
AL-Salam, S., Alashari, M. & Ghazal-Aswad, S. Expression of insulin-like growth factor-1 receptors, Wilm’s tumor-1 protein, c-kit and p16 in primary fallopian tube carcinoma in diabetic patients. Arch Gynecol Obstet 277, 449–455 (2008). https://doi.org/10.1007/s00404-007-0494-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-007-0494-2